ARIMIDEX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ARIMIDEX contains one active pharmaceutical ingredient (API):

1 Anastrozole UNII 2Z07MYW1AZ - ANASTROZOLE

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. Read about Anastrozole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ARIMIDEX Film-coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BG03	Anastrozole	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8179L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502300201115318
Country: CA	Health Products and Food Branch	Identifier(s): 02224135
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00313704, 00564642, 00956106, 03931302, 05567705, 06919773, 07511985, 07511991
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21650-1-11-04
Country: EE	Ravimiamet	Identifier(s): 1033546, 1552722, 1552733, 1552744, 1552755, 1552766, 1552777
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 2268001, 44-1296-97-C, 44579, 61286
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 386953
Country: FR	Base de données publique des médicaments	Identifier(s): 62303214, 69890344
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 198662, 198723, 20074
Country: HK	Department of Health Drug Office	Identifier(s): 42327
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-226665669
Country: IE	Health Products Regulatory Authority	Identifier(s): 12935, 12976, 12978
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4747
Country: IT	Agenzia del Farmaco	Identifier(s): 031809015
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291010F1031
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002936
Country: MT	Medicines Authority	Identifier(s): PI908/09501B
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 263M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 45020
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7569
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080088
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67720001
Country: SG	Health Sciences Authority	Identifier(s): 09433P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5683142H, 5683143H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699586094163
Country: US	FDA, National Drug Code	Identifier(s): 62559-670
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/21.12/0495